Christopher J. Rito

Person

Martinsville, IN, US

People

Patents Grantslast 30 patents

Information Patent Grant
Oxazolyl-aryloxyacetic acid derivatives and their use as PPAR agonists
- Patent number 7,351,728
- Issue date Apr 1, 2008
- Eli Lilly and Company
- Dawn Alisa Brooks
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Peroxisome proliferator activated receptor agonists
- Patent number 7,345,070
- Issue date Mar 18, 2008
- Eli Lilly and Company
- Dawn Alisa Brooks
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Oxazolyl-aryloxyacetic acid derivatives and their use as PPAR agonists
- Patent number 7,176,224
- Issue date Feb 13, 2007
- Eli Lilly and Company
- Robert J Ardecky
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Selective β3 adrenergic agonists
- Patent number 7,041,684
- Issue date May 9, 2006
- Eli Lilly and Company
- Christopher J. Rito
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Oxazolyl-arylproplonic acid derivatives and their use as ppar agonists
- Patent number 6,930,120
- Issue date Aug 16, 2005
- Eli Lilly and Company
- Dawn Alisa Brooks
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Modulators of peroxisome proliferator activated receptors
- Patent number 6,825,222
- Issue date Nov 30, 2004
- Eli Lilly and Company
- Dawn A. Brooks
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Selective β3 adrenergic agonists
- Patent number 6,686,372
- Issue date Feb 3, 2004
- Eli Lilly and Company
- Thomas A. Crowell
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Modulators of peroxisome proliferator activated receptors
- Patent number 6,610,696
- Issue date Aug 26, 2003
- Eli Lilly and Company
- Dawn A. Brooks
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Modulators of peroxisome proliferator activated receptors
- Patent number 6,417,212
- Issue date Jul 9, 2002
- Eli Lilly and Company
- Dawn A. Brooks
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Selective β3 adrenergic agonists
- Patent number 6,413,991
- Issue date Jul 2, 2002
- Eli Lilly and Company
- Thomas A. Crowell
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Selective β3 adrenergic agonists
- Patent number 6,265,581
- Issue date Jul 24, 2001
- Eli Lilly and Company
- Michael Gregory Bell
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Carbazolyl-substituted ethanolamines as selective .beta.-.sub.3 ago...
- Patent number 6,140,352
- Issue date Oct 31, 2000
- Eli Lilly and Company
- Thomas A. Crowell
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Selective .beta.-3 adrenergic agonists
- Patent number 6,093,735
- Issue date Jul 25, 2000
- Eli Lilly and Company
- Michael Gregory Bell
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Selective .beta..sub.3 adrenergic agonists
- Patent number 6,075,040
- Issue date Jun 13, 2000
- Eli Lilly and Company
- Michael Gregory Bell
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Process for preparing bis-indoly macrocycles
- Patent number 6,057,440
- Issue date May 2, 2000
- Eli Lilly and Company
- William F. Heath
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Selective .beta.3 adrenergic agonist
- Patent number 5,977,154
- Issue date Nov 2, 1999
- Eli Lilly and Company
- Michael Gregory Bell
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Selective .beta.3 adrenergic agonists
- Patent number 5,939,443
- Issue date Aug 17, 1999
- Eli Lilly and Company
- Michael Gregory Bell
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Protein kinase C inhibitors
- Patent number 5,843,935
- Issue date Dec 1, 1998
- Eli Lilly and Company
- William F. Heath
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Selective .beta.-3 adrenergic agonists
- Patent number 5,840,738
- Issue date Nov 24, 1998
- Eli Lilly and Company
- Michael Gregory Bell
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Process for preparing bis-indolyl macrocycles
- Patent number 5,821,365
- Issue date Oct 13, 1998
- Eli Lilly and Company
- Michael R. Jirousek
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Therapeutic treatment of cancer with Protein Kinase C inhibitors
- Patent number 5,780,461
- Issue date Jul 14, 1998
- Eli Lilly and Company
- William F. Heath
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Process for preparing BIS-indolyl macrocycles
- Patent number 5,739,322
- Issue date Apr 14, 1998
- Eli Lilly and Company
- William F. Heath
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Protein kinase C inhibitors
- Patent number 5,719,175
- Issue date Feb 17, 1998
- Eli Lilly and Company
- William F. Heath
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Protein kinase C inhibitors
- Patent number 5,698,578
- Issue date Dec 16, 1997
- Eli Lilly and Company
- William F. Heath
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Protein kinase C inhibitors
- Patent number 5,696,108
- Issue date Dec 9, 1997
- Eli Lilly and Company
- William F. Heath
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods of treating diabetic mellitus and its complications
- Patent number 5,674,862
- Issue date Oct 7, 1997
- Eli Lilly and Company
- William F. Heath
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Protein kinase C inhibitors
- Patent number 5,624,949
- Issue date Apr 29, 1997
- Eli Lilly and Company
- William F. Heath
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Process for preparing bis-indolyl macrocycles
- Patent number 5,621,098
- Issue date Apr 15, 1997
- Eli Lilly and Company
- William F. Heath
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Protein kinase c inhibitors
- Patent number 5,552,396
- Issue date Sep 3, 1996
- Eli Lilly and Company
- William F. Heath
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
OXAZOLYL-ARYLOXYACETIC ACID DERIVATIVES AND THEIR USE AS PPAR AGONISTS
- Publication number 20080146631
- Publication date Jun 19, 2008
- Dawn Alisa Brooks
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Oxazolyl-aryloxyacetic acid derivatives and their use as PPAR agonists
- Publication number 20050250825
- Publication date Nov 10, 2005
- Dawn Alisa Brooks
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Peroxisome proliferator activated receptor agonists
- Publication number 20050245584
- Publication date Nov 3, 2005
- Dawn Alisa Brooks
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Selective beta3 adrenergic agonists
- Publication number 20050043337
- Publication date Feb 24, 2005
- Christopher J. Rito
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Oxazolyl-aryloxyacetic acid derivatives and their use as ppar agonists
- Publication number 20040138277
- Publication date Jul 15, 2004
- Robert J Ardecky
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Oxazolyl-arylpropionic acid derivatives and their use as ppar agonists
- Publication number 20040097590
- Publication date May 20, 2004
- Dawn Alisa Brooks
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Oxazolyl-aryloxyacetic acid derivatives and their use as ppar agonists
- Publication number 20040024034
- Publication date Feb 5, 2004
- Dawn Alisa Brooks
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Modulators of peroxisome proliferator activated receptors
- Publication number 20040019090
- Publication date Jan 29, 2004
- Eli Lilly and Company
- Dawn A. Brooks
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Modulators of peroxisome proliferator activated receptors
- Publication number 20030045558
- Publication date Mar 6, 2003
- Eli Lilly & Company Lily Corporate Center
- Dawn A. Brooks
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Selective B3 adrenergic agonists
- Publication number 20020165234
- Publication date Nov 7, 2002
- Thomas A. Crowell
- C07 - ORGANIC CHEMISTRY

Christopher J. Rito

Person

Patents Grantslast 30 patents

Oxazolyl-aryloxyacetic acid derivatives and their use as PPAR agonists

Peroxisome proliferator activated receptor agonists

Oxazolyl-aryloxyacetic acid derivatives and their use as PPAR agonists

Selective β3 adrenergic agonists

Oxazolyl-arylproplonic acid derivatives and their use as ppar agonists

Modulators of peroxisome proliferator activated receptors

Selective &#x03B2;3 adrenergic agonists

Modulators of peroxisome proliferator activated receptors

Modulators of peroxisome proliferator activated receptors

Selective &#x03B2;3 adrenergic agonists

Selective &#x03B2;3 adrenergic agonists

Carbazolyl-substituted ethanolamines as selective .beta.-.sub.3 ago...

Selective .beta.-3 adrenergic agonists

Selective .beta..sub.3 adrenergic agonists

Process for preparing bis-indoly macrocycles

Selective .beta.3 adrenergic agonist

Selective .beta.3 adrenergic agonists

Protein kinase C inhibitors

Selective .beta.-3 adrenergic agonists

Process for preparing bis-indolyl macrocycles

Therapeutic treatment of cancer with Protein Kinase C inhibitors

Process for preparing BIS-indolyl macrocycles

Protein kinase C inhibitors

Protein kinase C inhibitors

Protein kinase C inhibitors

Methods of treating diabetic mellitus and its complications

Protein kinase C inhibitors

Process for preparing bis-indolyl macrocycles

Protein kinase c inhibitors

Patents Applicationslast 30 patents

OXAZOLYL-ARYLOXYACETIC ACID DERIVATIVES AND THEIR USE AS PPAR AGONISTS

Oxazolyl-aryloxyacetic acid derivatives and their use as PPAR agonists

Peroxisome proliferator activated receptor agonists

Selective beta3 adrenergic agonists

Oxazolyl-aryloxyacetic acid derivatives and their use as ppar agonists

Oxazolyl-arylpropionic acid derivatives and their use as ppar agonists

Oxazolyl-aryloxyacetic acid derivatives and their use as ppar agonists

Modulators of peroxisome proliferator activated receptors

Modulators of peroxisome proliferator activated receptors

Selective B3 adrenergic agonists

Selective β3 adrenergic agonists

Selective β3 adrenergic agonists

Selective β3 adrenergic agonists